Home › Evotec And Ex Scientia Announce Partnership To Discover Bispecific Small Molecule Immuno-Oncology Therapeutics
 

Keywords :   


Evotec And Ex Scientia Announce Partnership To Discover Bispecific Small Molecule Immuno-Oncology Therapeutics

2016-05-03 03:19:19| drugdiscoveryonline News Articles

Evotec AG and ex scientia Ltd (Dundee, UK) recently announced a collaboration with the objective to discover and develop first-in-class bispecific small molecule immuno-oncology therapies

Tags: small partnership discover announce

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
28.06Tropical Depression Two Forecast Discussion Number 1
28.06Tropical Depression Two Wind Speed Probabilities Number 1
More »